Brian Taylor Slingsby

Insider Reports History

Entity
Individual
Location
C/O Mineralys Therapeutics, Inc., 150 N. Radnor Chester Rd, Ste. F200, Radnor, PA
Signature
/s/ Adam Levy, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Taylor Slingsby:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director, 10%+ Owner Common Stock 8.64M $113M $13.05 Jul 24, 2024 Indirect
Mineralys Therapeutics, Inc. Director, 10%+ Owner Stock Option 22K May 22, 2024 Direct

Insider Reports Filed by Brian Taylor Slingsby

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLYS Mineralys Therapeutics, Inc. Jul 24, 2024 1 -$7.18M 4 Jul 26, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. May 22, 2024 1 $0 4 May 23, 2024 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Jul 12, 2023 2 $0 4 Jul 14, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 14, 2023 4 $4M 4 Feb 16, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 1 $0 4 Feb 13, 2023 Director, 10%+ Owner
MLYS Mineralys Therapeutics, Inc. Feb 9, 2023 0 $0 3 Feb 9, 2023 Director, 10%+ Owner